| NCT03337048 |
Exploratory Study Investigating Urodynamic Parameters During Catheterisation |
https://ClinicalTrials.gov/show/NCT03337048 |
Completed |
Coloplast A/S |
2018-05-29 |
| NCT03249987 |
Comparing the Usability of an Electronic Bladder Diary and a Paper Bladder Diary |
https://ClinicalTrials.gov/show/NCT03249987 |
Completed |
Sheffield Teaching Hospitals NHS Foundation Trust |
2018-04-30 |
| NCT03239652 |
Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT03239652 |
Recruiting |
National Cheng-Kung University Hospital |
2020-06-30 |
| NCT03230721 |
ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPH |
https://ClinicalTrials.gov/show/NCT03230721 |
Completed |
I.M. Sechenov First Moscow State Medical University |
2017-04-22 |
| NCT03104907 |
Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03104907 |
Completed |
Rigshospitalet, Denmark |
2018-11-27 |
| NCT03099421 |
Prostatic Artery Embolization for Benign Prostatic Obstruction |
https://ClinicalTrials.gov/show/NCT03099421 |
Completed |
Rigshospitalet, Denmark |
2018-12-14 |
| NCT02972268 |
Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH |
https://ClinicalTrials.gov/show/NCT02972268 |
Completed |
Jeil Pharmaceutical Co., Ltd. |
2017-11-02 |
| NCT02930889 |
Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT02930889 |
Recruiting |
University of Minnesota |
2020-10-31 |
| NCT02758938 |
Urological Biofeedback Game Software |
https://ClinicalTrials.gov/show/NCT02758938 |
Completed |
University of Wisconsin, Madison |
2018-01-31 |
| NCT02757768 |
A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT02757768 |
Completed |
Astellas Pharma Inc |
2018-08-14 |
| NCT02748356 |
Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB |
https://ClinicalTrials.gov/show/NCT02748356 |
Completed |
Medstar Health Research Institute |
2018-10-21 |
| NCT02748317 |
Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB |
https://ClinicalTrials.gov/show/NCT02748317 |
Completed |
Medstar Health Research Institute |
2018-10-31 |
| NCT02742389 |
Urodynamic Testing: Can we Improve Patient Experience? |
https://ClinicalTrials.gov/show/NCT02742389 |
Completed |
Boston Urogynecology Associates |
2017-06-30 |
| NCT02715024 |
Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms |
https://ClinicalTrials.gov/show/NCT02715024 |
Completed |
Astellas Pharma Inc |
2011-04-30 |
| NCT02676544 |
Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH) |
https://ClinicalTrials.gov/show/NCT02676544 |
Recruiting |
Rhode Island Hospital |
2020-12-31 |
| NCT02673944 |
Portable Pves Study |
https://ClinicalTrials.gov/show/NCT02673944 |
Completed |
Laborie Medical Technologies Inc. |
2016-03-31 |
| NCT02634489 |
EC905 Pharmacokinetic Profile Study |
https://ClinicalTrials.gov/show/NCT02634489 |
Completed |
Astellas Pharma Inc |
2009-07-31 |
| NCT02592473 |
Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT02592473 |
Recruiting |
University of Virginia |
2021-11-30 |
| NCT02554201 |
Efficacy of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract Dysfunction |
https://ClinicalTrials.gov/show/NCT02554201 |
Completed |
Shanghai Institute of Acupuncture, Moxibustion and Meridian |
2016-10-31 |
| NCT02494349 |
The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. |
https://ClinicalTrials.gov/show/NCT02494349 |
Completed |
Jeil Pharmaceutical Co., Ltd. |
2015-11-30 |
| NCT02462837 |
Myrbetriqâ„¢ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement |
https://ClinicalTrials.gov/show/NCT02462837 |
Completed |
Southern Illinois University |
2019-01-30 |
| NCT02366975 |
TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST |
https://ClinicalTrials.gov/show/NCT02366975 |
Completed |
University of Florence |
2017-01-31 |
| NCT02332538 |
HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH |
https://ClinicalTrials.gov/show/NCT02332538 |
Completed |
Mansoura University |
2016-07-31 |
| NCT02330107 |
Auriculotherapy on Lower Urinary Tract Symptoms in Elderly Men |
https://ClinicalTrials.gov/show/NCT02330107 |
Completed |
The Hong Kong Polytechnic University |
2017-06-30 |
| NCT02326454 |
A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT02326454 |
Completed |
Light Sciences Oncology |
2017-03-29 |
| NCT02291432 |
Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery |
https://ClinicalTrials.gov/show/NCT02291432 |
Completed |
Cook MyoSite |
2019-06-28 |
| NCT02272309 |
Neurophysiological Assessment of Healthy and Impaired Human Lower Urinary Tract Function |
https://ClinicalTrials.gov/show/NCT02272309 |
Recruiting |
University of Zurich |
2023-12-31 |
| NCT02271607 |
The Effect and Safety of Moxibustion Therapy for Overactive Bladder Patients |
https://ClinicalTrials.gov/show/NCT02271607 |
Completed |
Korean Medicine Hospital of Pusan National University |
2015-12-31 |
| NCT02252367 |
Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT02252367 |
Active, not recruiting |
University of Florence |
2019-01-31 |
| NCT02245490 |
Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms |
https://ClinicalTrials.gov/show/NCT02245490 |
Completed |
Boehringer Ingelheim |
2004-04-30 |
| NCT02244281 |
Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms |
https://ClinicalTrials.gov/show/NCT02244281 |
Completed |
Boehringer Ingelheim |
2003-11-30 |
| NCT02193451 |
Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods |
https://ClinicalTrials.gov/show/NCT02193451 |
Active, not recruiting |
North Bristol NHS Trust |
2018-07-31 |
| NCT02074644 |
Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT02074644 |
Completed |
Hospital St. Louis, Lisbon, Portugal |
2019-03-03 |
| NCT01282840 |
Bladder Wall Blood Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarincs for Female Overactive Bladder Syndrome. |
https://ClinicalTrials.gov/show/NCT01282840 |
Completed |
Far Eastern Memorial Hospital |
2018-11-05 |
| NCT02051036 |
Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study |
https://ClinicalTrials.gov/show/NCT02051036 |
Completed |
Korean Medicine Hospital of Pusan National University |
2015-12-31 |
| NCT01963312 |
Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms. |
https://ClinicalTrials.gov/show/NCT01963312 |
Completed |
Fundacion Miguel Servet |
2018-04-30 |
| NCT01939756 |
Intravesical Natural Baobab Oil in the Management of BCG-induced Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT01939756 |
Completed |
University of Rome Tor Vergata |
2013-06-30 |
| NCT01939184 |
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT01939184 |
Completed |
Warner Chilcott |
2014-03-31 |
| NCT01922375 |
Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT01922375 |
Completed |
Dong-A ST Co., Ltd. |
2012-09-30 |
| NCT01912339 |
Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate) |
https://ClinicalTrials.gov/show/NCT01912339 |
Completed |
Boston Scientific Corporation |
2015-03-31 |
| NCT01846793 |
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022) |
https://ClinicalTrials.gov/show/NCT01846793 |
Completed |
Nymox Corporation |
2014-10-31 |
| NCT01822288 |
The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder |
https://ClinicalTrials.gov/show/NCT01822288 |
Recruiting |
Far Eastern Memorial Hospital |
2021-12-31 |
| NCT01812928 |
Diclofenac Suppository to Control Pain During Flexible Cystoscopy |
https://ClinicalTrials.gov/show/NCT01812928 |
Completed |
Aga Khan University |
2013-08-31 |
| NCT01726270 |
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms |
https://ClinicalTrials.gov/show/NCT01726270 |
Completed |
Boehringer Ingelheim |
2013-03-31 |
| NCT01570673 |
Group Versus Individual Urotherapy for Children |
https://ClinicalTrials.gov/show/NCT01570673 |
Completed |
Hamilton Health Sciences Corporation |
2014-05-31 |
| NCT01457573 |
Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT01457573 |
Completed |
The Methodist Hospital System |
2014-07-31 |
| NCT01454349 |
Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT01454349 |
Completed |
Sophiris Bio Corp |
2013-03-31 |
| NCT01381120 |
Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT01381120 |
Completed |
Barrie Urology Associates |
2012-06-30 |
| NCT04391114 |
Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT04391114 |
Recruiting |
Thunder Bay Regional Research Institute |
2021-10-15 |
| NCT04386941 |
Greenlight Vaporization vs Xpeeda Vaporesection |
https://ClinicalTrials.gov/show/NCT04386941 |
Recruiting |
Thunder Bay Regional Research Institute |
2022-07-10 |
| NCT04284761 |
A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT04284761 |
Recruiting |
Alessa Therapeutics Inc. |
2020-09-30 |
| NCT04198103 |
Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT04198103 |
Active, not recruiting |
University of Rome Tor Vergata |
2019-11-01 |
| NCT04102566 |
Optimizing Pain Control in Transurethral Resection of the Prostate |
https://ClinicalTrials.gov/show/NCT04102566 |
Recruiting |
Benaroya Research Institute |
2019-10-01 |
| NCT04044573 |
Focal Laser Ablation for Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT04044573 |
Recruiting |
University of Rome Tor Vergata |
2023-04-05 |
| NCT03936244 |
Bipolar Plasmakinetic TURP Versus Monopolar TURP in the Treatment of Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT03936244 |
Active, not recruiting |
Hospital Universitario de Fuenlabrada |
2017-12-12 |
| NCT03865459 |
The Effect of Watching Relaxing Video During Cystoscopy |
https://ClinicalTrials.gov/show/NCT03865459 |
Completed |
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi |
2018-03-22 |
| NCT03856242 |
Benign Prostatic Hyperplasia and Ischemic Heart DIsease |
https://ClinicalTrials.gov/show/NCT03856242 |
Completed |
I.M. Sechenov First Moscow State Medical University |
2017-09-01 |
| NCT03833752 |
Flexible V/S Rigid Cystoscopy In Men With Urinary Tract Infection |
https://ClinicalTrials.gov/show/NCT03833752 |
Completed |
Maulana Azad Medical College |
2017-12-31 |
| NCT03831321 |
The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy |
https://ClinicalTrials.gov/show/NCT03831321 |
Recruiting |
Istanbul Medeniyet University |
2019-04-22 |
| NCT03817931 |
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder |
https://ClinicalTrials.gov/show/NCT03817931 |
Recruiting |
Baylor Research Institute |
2020-05-01 |
| NCT03802851 |
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer |
https://ClinicalTrials.gov/show/NCT03802851 |
Recruiting |
University of Kansas Medical Center |
2030-01-31 |
| NCT03772808 |
Effects of LycoComfortâ„¢ Supplementation on Symptoms Associated With Lower Urinary Tract Symptoms (LUTS) |
https://ClinicalTrials.gov/show/NCT03772808 |
Completed |
LycoRed Ltd. |
2019-04-30 |
| NCT03750656 |
Use of Hyoscyamine Versus Tamsulosin for Management of Ureteral Stent Irritation |
https://ClinicalTrials.gov/show/NCT03750656 |
Recruiting |
University of Kansas Medical Center |
2021-11-30 |
| NCT03729336 |
PEEZY Midstream Urine Device Compared to Catheterized Urine Sample |
https://ClinicalTrials.gov/show/NCT03729336 |
Completed |
Baylor Research Institute |
2019-04-12 |
| NCT03713411 |
Is Urethral Catheter Necessary After Ureteroscopy and DJ Stent Placement? |
https://ClinicalTrials.gov/show/NCT03713411 |
Recruiting |
Marmara University |
2020-04-01 |
| NCT03669692 |
Open Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. |
https://ClinicalTrials.gov/show/NCT03669692 |
Recruiting |
Complexo Hospitalario Universitario de A Coruña |
2022-12-10 |
| NCT03633994 |
Heparin Intraoperative Instillation for Lower Urinary Tract Symptoms After Benign Hysterectomy |
https://ClinicalTrials.gov/show/NCT03633994 |
Recruiting |
The Christ Hospital |
2019-12-31 |
| NCT03625492 |
Fluids Affecting Bladder Urgency and Lower Urinary Symptoms |
https://ClinicalTrials.gov/show/NCT03625492 |
Completed |
University of Michigan |
2019-09-17 |
| NCT03623880 |
Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders |
https://ClinicalTrials.gov/show/NCT03623880 |
Recruiting |
Northwestern University |
2020-09-30 |
| NCT03605745 |
Minimally Invasive Prostatic Vapor Ablation for the Treatment of BPH in Large Prostates (Rezūm XL) |
https://ClinicalTrials.gov/show/NCT03605745 |
Active, not recruiting |
Boston Scientific Corporation |
2020-09-30 |
| NCT03603015 |
Contractility: Cuff Versus Urodynamics Testing In Males With Voiding Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT03603015 |
Recruiting |
Newcastle-upon-Tyne Hospitals NHS Trust |
2019-03-31 |
| NCT03527589 |
Embosphere® PROstate Post Market Study |
https://ClinicalTrials.gov/show/NCT03527589 |
Active, not recruiting |
Merit Medical Systems, Inc. |
2022-09-01 |
| NCT03524339 |
Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery |
https://ClinicalTrials.gov/show/NCT03524339 |
Completed |
University Hospitals Cleveland Medical Center |
2020-06-09 |
| NCT03450811 |
Effect of Inguinal Hernia Repair on Uroflowmetric Parameteres |
https://ClinicalTrials.gov/show/NCT03450811 |
Completed |
Ankara Training and Research Hospital |
2018-02-20 |
| NCT03434873 |
Effect of Motor Cortex Versus Sacral Magnetic Stimulation in Multiple Sclerosis Patients With Urinary Tract Dysfunction |
https://ClinicalTrials.gov/show/NCT03434873 |
Completed |
Cairo University |
2015-04-30 |
| NCT01260129 |
Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH |
https://ClinicalTrials.gov/show/NCT01260129 |
Completed |
JW Pharmaceutical |
2010-11-30 |
| NCT01175382 |
Combined Behavioral and Drug Treatment of Overactive Bladder in Men |
https://ClinicalTrials.gov/show/NCT01175382 |
Completed |
University of Alabama at Birmingham |
2015-07-31 |
| NCT01042249 |
Pelvic Floor Muscle Training(PFMT) on Lower Urinary Tract Symptoms (LUTS) in Men With Stroke |
https://ClinicalTrials.gov/show/NCT01042249 |
Completed |
Glostrup University Hospital, Copenhagen |
2017-04-26 |
| NCT01021332 |
Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT01021332 |
Completed |
Astellas Pharma Inc |
2011-12-14 |
| NCT01018511 |
Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT01018511 |
Completed |
Astellas Pharma Inc |
2011-03-31 |
| NCT01002664 |
Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT01002664 |
Completed |
Health Ever Bio-Tech Co., Ltd. |
2014-06-30 |
| NCT01002417 |
MCS in the Treatment of Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT01002417 |
Completed |
Health Ever Bio-Tech Co., Ltd. |
2014-02-28 |
| NCT01002274 |
Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT01002274 |
Completed |
Health Ever Bio-Tech Co., Ltd. |
2014-06-30 |
| NCT01002222 |
Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c) |
https://ClinicalTrials.gov/show/NCT01002222 |
Completed |
Health Ever Bio-Tech Co., Ltd. |
2014-02-28 |
| NCT00947882 |
A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT00947882 |
Completed |
Ferring Pharmaceuticals |
2011-03-31 |
| NCT00939120 |
Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) |
https://ClinicalTrials.gov/show/NCT00939120 |
Completed |
Siami, Paul F., M.D. |
2014-09-30 |
| NCT00918034 |
Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT00918034 |
Completed |
Light Sciences Oncology |
2011-02-28 |
| NCT00908427 |
Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00908427 |
Completed |
Samsung Medical Center |
2006-05-31 |
| NCT00893113 |
An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT00893113 |
Completed |
Chesapeake Urology Research Associates |
2012-10-31 |
| NCT00877669 |
Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH |
https://ClinicalTrials.gov/show/NCT00877669 |
Completed |
Samsung Medical Center |
2016-07-31 |
| NCT04418635 |
Herbal Supplement Prosta-OK® Neo as an Adjunct Therapy in Patients With Mild to Severe Non-neurogenic Male Lower Urinary Tract Symptoms Receiving Tamsulosin Therapy |
https://ClinicalTrials.gov/show/NCT04418635 |
Recruiting |
Acrobio Healthcare Inc. |
2021-12-31 |
| NCT03055624 |
Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT03055624 |
Completed |
University of California, San Diego |
2019-02-18 |
| NCT00836823 |
Evaluation of Symptom-specific Goal Achievement |
https://ClinicalTrials.gov/show/NCT00836823 |
Completed |
Samsung Medical Center |
2008-08-31 |
| NCT03625843 |
Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing |
https://ClinicalTrials.gov/show/NCT03625843 |
Completed |
San Antonio Uniformed Services Health Education Consortium |
2017-12-30 |
| NCT01966614 |
Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH |
https://ClinicalTrials.gov/show/NCT01966614 |
Completed |
Sophiris Bio Corp |
2015-12-31 |
| NCT02856217 |
Impact of Tunneling During Minimally Invasive Sacrocolpopexy |
https://ClinicalTrials.gov/show/NCT02856217 |
Completed |
The University of Texas Medical Branch, Galveston |
2017-09-30 |
| NCT02180789 |
A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation |
https://ClinicalTrials.gov/show/NCT02180789 |
Completed |
Astellas Pharma Inc |
2015-01-31 |
| NCT03520166 |
Use of Medium Frequency Electrotherapy in the Treatment of OAB, LUTS and Pelvic Pain |
https://ClinicalTrials.gov/show/NCT03520166 |
Completed |
Fisioterapia Pélvica Avanzada Madrid, SRL |
2017-06-15 |
| NCT00710749 |
The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects |
https://ClinicalTrials.gov/show/NCT00710749 |
Completed |
Wellspect HealthCare |
2009-04-30 |
| NCT00709488 |
Phase 1 Study of the Litxâ„¢ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT00709488 |
Completed |
Light Sciences Oncology |
2011-04-30 |
| NCT00706407 |
Uro-NIRS Clinical Study |
https://ClinicalTrials.gov/show/NCT00706407 |
Completed |
Weill Medical College of Cornell University |
2010-05-31 |
| NCT00693199 |
Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension |
https://ClinicalTrials.gov/show/NCT00693199 |
Completed |
Anhui Medical University |
2006-10-31 |
| NCT00575913 |
Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study |
https://ClinicalTrials.gov/show/NCT00575913 |
Completed |
Sanofi |
NA |
| NCT00510406 |
A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH |
https://ClinicalTrials.gov/show/NCT00510406 |
Completed |
Astellas Pharma Inc |
2007-09-30 |
| NCT00507455 |
Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction |
https://ClinicalTrials.gov/show/NCT00507455 |
Completed |
Astellas Pharma Inc |
2008-08-31 |
| NCT00457457 |
Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms. |
https://ClinicalTrials.gov/show/NCT00457457 |
Completed |
Pfizer |
2008-04-30 |
| NCT00427219 |
The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate |
https://ClinicalTrials.gov/show/NCT00427219 |
Completed |
Spectrum Pharmaceuticals, Inc |
2008-04-30 |
| NCT00410514 |
A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO) |
https://ClinicalTrials.gov/show/NCT00410514 |
Completed |
Astellas Pharma Inc |
2008-08-31 |
| NCT00409357 |
Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00409357 |
Completed |
Sanofi |
2005-08-31 |
| NCT00408954 |
Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT00408954 |
Completed |
Pfizer |
2008-06-30 |
| NCT00338624 |
An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms. |
https://ClinicalTrials.gov/show/NCT00338624 |
Completed |
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. |
NA |
| NCT00270309 |
Self-management for Men With Uncomplicated Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT00270309 |
Completed |
The Royal College of Surgeons of England |
2004-04-30 |
| NCT00111592 |
Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice |
https://ClinicalTrials.gov/show/NCT00111592 |
Completed |
Maastricht University Medical Center |
NA |
| NCT00540891 |
The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score |
https://ClinicalTrials.gov/show/NCT00540891 |
Completed |
Sanofi |
NA |